For: | Dietrich CG, Rau M, Geier A. Screening for nonalcoholic fatty liver disease-when, who and how? World J Gastroenterol 2021; 27(35): 5803-5821 [PMID: 34629804 DOI: 10.3748/wjg.v27.i35.5803] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i35/5803.htm |
Number | Citing Articles |
1 |
Michelle J Allen, Rachael Doran, David Brain, Elizabeth E Powell, James O’Beirne, Patricia C Valery, Adrian Barnett, Ruvini Hettiarachchi, Ingrid J Hickman, Sanjeewa Kularatna. A discrete choice experiment to elicit preferences for a liver screening programme in Queensland, Australia: a mixed methods study to select attributes and levels. BMC Health Services Research 2023; 23(1) doi: 10.1186/s12913-023-09934-2
|
2 |
Markos Kalligeros, Athanasios Vassilopoulos, Fadi Shehadeh, Stephanos Vassilopoulos, Ingrid Lazaridou, Eleftherios Mylonakis, Kittichai Promrat, Jack R. Wands. Prevalence and Characteristics of Nonalcoholic Fatty Liver Disease and Fibrosis in People Living With HIV Monoinfection: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 2023; 21(7): 1708 doi: 10.1016/j.cgh.2023.01.001
|
3 |
Jhon Edison Prieto Ortíz, Carlos Bernardo Sánchez Luque, Rolando José Ortega Quiróz. Hígado graso (parte 2): enfoque clínico y tratamiento. Revista colombiana de Gastroenterología 2023; 38(1): 46 doi: 10.22516/25007440.979
|
4 |
Chun-Yi Wang, Hsiang-Han Kao, Kuan-Yu Lai, Ching-Chun Lin, Wen-Yuan Lin, Chiu-Shong Liu, Tsung-Po Chen. Clinical and Metabolic Characteristics of Hyperuricemia with Risk of Liver Fibrosis: A Cross-Sectional Study. Metabolites 2022; 12(10): 893 doi: 10.3390/metabo12100893
|
5 |
Adnan Khan, Heather M. Ross, Natalia Salinas Parra, Sarah L. Chen, Kashyap Chauhan, Makala Wang, Brian Yan, John Magagna, Jake Beiriger, Yash Shah, Taha Shahzad, Dina Halegoua-DeMarzio. Risk Prevention and Health Promotion for Non-Alcoholic Fatty Liver Diseases (NAFLD). Livers 2022; 2(4): 264 doi: 10.3390/livers2040022
|
6 |
Menooa Ebrahimi, Seyed Arsalan Seyedi, Seyed Ali Nabipoorashrafi, Soghra Rabizadeh, Mojdeh Sarzaeim, Amirhossein Yadegar, Fatemeh Mohammadi, Razman Arabzadeh Bahri, Peyman Pakravan, Paria Shafiekhani, Manouchehr Nakhjavani, Alireza Esteghamati. Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis. Lipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01802-6
|
7 |
Akira Sasaki, Akira Umemura, Kazuyuki Ishida, Naoto Takahashi, Haruka Nikai, Hiroyuki Nitta, Yasuhiro Takikawa, Keisuke Kakisaka, Tamami Abe, Masao Nishiya, Tamotsu Sugai. The Concept of Indeterminable NASH Inducted by Preoperative Diet and Metabolic Surgery: Analyses of Histopathological and Clinical Features. Biomedicines 2022; 10(2): 453 doi: 10.3390/biomedicines10020453
|
8 |
Barbara Janota, Elżbieta Szczepańska, Brygida Adamek, Ewa Janczewska. Hypothyroidism and non-alcoholic fatty liver disease: A coincidence or a causal relationship?. World Journal of Hepatology 2023; 15(5): 641-648 doi: 10.4254/wjh.v15.i5.641
|
9 |
Pei Chia Eng, Roberta Forlano, Tricia Tan, Pinelopi Manousou, Waljit S. Dhillo, Chioma Izzi-Engbeaya. Non-alcoholic fatty liver disease in women – Current knowledge and emerging concepts. JHEP Reports 2023; 5(10): 100835 doi: 10.1016/j.jhepr.2023.100835
|
10 |
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders. World Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828
|